Kathleen Starkoff
CIK: 0001755126
Associated companies
Transaction History
| GNTX | ▲ Buy | Grant | 5,626 | $0 | 5/21/2026 | View on chart |
| GNTX | ▲ Buy | Grant | 5,939 | $0 | 5/15/2025 | View on chart |
| GNTX | ▲ Buy | Grant | 3,764 | $0 | 5/16/2024 | View on chart |
| GNTX | ▲ Buy | Option Exercise | 4,430 | $95K | 7/31/2023 | View on chart |
| GNTX | ▼ Sell | Open Market | 4,430 | $147K | 7/31/2023 | View on chart |
| GNTX | ▲ Buy | Grant | 4,716 | $0 | 5/18/2023 | View on chart |
| GNTX | ▲ Buy | Grant | 3,397 | $0 | 5/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Goldman Sachs downgrades Gentex to Sell, UBS cuts target
Goldman Sachs downgraded Gentex to Sell and lowered its price target to $20, while UBS maintained a Neutral rating but cut its target to $24. These moves reflect growing concerns about the automotive sector, with one analyst noting the stock is cheap but wary of industry headwinds. The stock currently trades near its 52-week low, with an average analyst target of $27.28.
Goldman Sachs downgrades Gentex to Sell, UBS cuts target. Goldman Sachs downgraded Gentex to Sell and lowered its price target to $20, while UBS maintained a Neutral rating but cut its target to $24. These moves reflect growing concerns about the automotive sector, with one analyst noting the stock is cheap but wary of industry headwinds. The stock currently trades near its 52-week low, with an average analyst target of $27.28.